Opening book details…
About this Medicine article
Phase 2 Clinical Evaluation of Preclinically Defined Biomarkers for Vascular Endothelial Growth Factor (Vegf) Tyrosine Kinase Inhibitor (Tki) Tivozanib in Renal Cell Carcinoma (Rcc) by T. Hutson; W.K. Rathmell; B. Feng; M.O. Robinson; J. Gyuris; J. Lin; T. Choueiri is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- T. Hutson; W.K. Rathmell; B. Feng; M.O. Robinson; J. Gyuris; J. Lin; T. Choueiri
- Publisher
- Oxford University Press; Elsevier BV (ISSN 0923-7534)
- Published
- 2014
- Language
- EN
- Field
- Medicine (Health Sciences)
More by T. Hutson; W.K. Rathmell; B. Feng; M.O. Robinson; J. Gyuris; J. Lin; T. Choueiri
Browse all works by T. Hutson; W.K. Rathmell; B. Feng; M.O. Robinson; J. Gyuris; J. Lin; T. Choueiri